1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Market Report, "Ghana Pharmaceuticals & Healthcare Report Q3 2011", published

Recently published research from Business Monitor International, "Ghana Pharmaceuticals & Healthcare Report Q3 2011", is now available at Fast Market Research

 
PRLog - Jul. 18, 2011 - BMI View: Ghana is one of the least attractive regional markets in the Middle East and Africa (MEA), judging by our proprietary MEA Business Environment Ratings (BER) matrix. However, the country's position masks a relatively favourable operating environment for multinationals, supported by policy continuity and strong economic growth. Nevertheless, the overall market size is modest, dragged down by low per capita spending, which was no higher than US$15 in 2010. In the longer term, however, rising population numbers and the prevalent disease burden, as well as the expected improvements in the country's regulatory environment, will boost Ghana's attractiveness to foreign drugmakers.

Headline Expenditure Projections

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/208360_ghana_pharmaceuticals_h...
------------------------------------------------------------

* Pharmaceuticals: GHC510mn (US$357mn) in 2010 to GHC557mn (US$382mn) in 2011; +9.1% in local currency terms and +7.1% in US dollar terms. Forecast down moderately from Q211 due to macroeconomic factors.
* Healthcare: GHC1.88bn (US$1.31bn) in 2010 to GHC2.13bn (US$1.46bn) in 2011; +13.4% in local currency terms and +11.3% in US dollar terms. Forecast down moderately from Q211 due to macroeconomic factors.
* Medical devices: GHC72mn (US$50mn) in 2010 to GHC81mn (US$56mn) in 2011; +12.9% in local currency terms and +10.8% in US dollar terms. Forecast down moderately from Q211 due to macroeconomic factors.


Business Environment Rating: In the Q311 BER for the 19 markets BMI surveys in the MEA region, Ghana receives a composite pharmaceutical rating of 39.5, which is 3.7% lower than in the previous quarter, due to the downwards adjustment of the industry rewards variable. Generally speaking, the country's scores are stronger on the risk than on the rewards side, primarily due to the low per capita spending on pharmaceuticals, which makes for a small overall market size.

Key Trends & Developments

* The health ministry of Ghana recently released Infection Prevention Control documents for hospitals, which include Infection Prevention Control Guidelines and the Standard Operating Procedure (SOP) for Tuberculoses (TB) and Airborne Infection Prevention and Control in the country, reported Public Agenda. The documents aim at spreading awareness among both healthcare workers and patients to prevent and control infections in hospitals. About 10% of the patients visiting healthcare facilities become infected with hospital-acquired infections.


BMI Economic View: We expect inflation to move back into double-digit figures by the end of the year, which will negatively impact the availability of funding for pharmaceuticals and healthcare services. This situation will be enhanced by the fact that the government provides under half of the total funding for healthcare expenditure. Nevertheless, we are forecasting double-digit economic growth for Ghana in 2011, with the onset of oil production set to drive the stellar performance. Still, we do acknowledge macroeconomic risks stemming from the issues regarding the budget and also from elevated inflation.

BMI Political View: Ghana's economic growth during the current year will be primarily driven by oil exports, but also strongly supported by buoyant foreign investment. We see this investment trend continuing over the medium term, with the country's overall economic development and infrastructure privatisation also providing an attractive involvement ground for drugmakers. Downward risks to our pharmaceutical and healthcare forecasts, however, are posed by the potential tightening of the budget, which has been suggested by the International Monetary Fund (IMF)'s delegation during its recent visit to the country.

Partial Table of Contents:

SWOT Analysis
- Ghana Pharmaceutical and healthcare SWOT
- Ghana Political SWOT
- Ghana Economic SWOT
- Ghana Business Environment SWOT
Pharmaceutical Business Environment Ratings
- Table: Middle East And Africa (MEA) - Regional Pharmaceutical Business Environment Ratings, Q311
- Rewards
- Risks
Ghana - Market Summary
Regulatory Regime
- Intellectual Property Regime
- Counterfeit Medicines
- Table: mPedigree's Activities In Ghana - Low-Cost Detection And Interception Technology
- Pricing And Reimbursement Regimes
- Rational Drug Prescribing
Industry Developments
- Epidemiology
- Communicable Diseases
- Non-Communicable Diseases
- Healthcare Sector
- Hospital Sector
- Recent Healthcare Sector Developments
- Health Insurance Sector
- Telemedicine
- Clinical Trials Sector
- Medical Devices Sector
Industry Forecast Scenario
- Overall Pharmaceutical Market Forecast
- Table: Pharmaceutical Sales Indicators 2007-2015
- Key Growth Factors - Industry
- Table: Healthcare Expenditure Indicators 2007-2015
- Table: Government Healthcare Expenditure Indicators 2007-2015
- Table: Private Healthcare Expenditure Indicators 2007-2015
- Key Growth Factors - Macroeconomic Outlook
- Table: Ghana - Economic Activity
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2007-2015
- Patented Market Forecast
- Table: Patented Drug Market Indicators 2007-2015
- Generic Drugs Market Forecast
- Table: Generic Drug Sales Indicators 2007-2015
- OTC Market Forecast
- Table: OTC Medicine Sales Indicators 2007-2015
- Medical Devices Market Forecast
- Table: Medical Devices Sales Indicators 2007-2015
- Pharmaceutical Trade Forecast
- Table: Exports and Imports Indicators 2007-2015
- Other Healthcare Data
- Key Risks To BMI Forecasts
Competitive Landscape
- Pharmaceutical Sector
- Domestic Pharmaceutical Industry
- Recent Pharmaceutical Sector Developments
- Pharmaceutical Distribution and Retail
Company Profiles
- Indigenous Pharmaceutical Firms
- LaGray Chemical Company
- Historical D
- DanAdams Pharmaceutical Industry
- Ayrton Drug Manufacturing Company (ADMC) (Adcock Ingram)

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=2083...

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

--- End ---

Click to Share

Contact Email:
***@fastmr.com Email Verified
Source:Fast Market Research
Phone:1.800.844.8156
Zip:01267
Location:Massachusetts - United States
Industry:Health, Medical, Research
Tags:per-capita, pharmaceuticals, Health, pharmaceutical, modest, mobile, hospitals, Healthcare, rewards, cagr
Shortcut:prlog.org/11588134
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share